Identifying novel glioma associated pathways based on systems biology level meta-analysis

BackgroundWith recent advances in microarray technology, including genomics, proteomics, and metabolomics, it brings a great challenge for integrating this "-omics" data to analysis complex disease. Glioma is an extremely aggressive and lethal form of brain tumor, and thus the study of the molecule mechanism underlying glioma remains very important. To date, most studies focus on detecting the differentially expressed genes in glioma. However, the meta-analysis for pathway analysis based on multiple microarray datasets has not been systematically pursued.ResultsIn this study, we therefore developed a systems biology based approach by integrating three types of omics data to identify common pathways in glioma. Firstly, the meta-analysis has been performed to study the overlapping of signatures at different levels based on the microarray gene expression data of glioma. Among these gene expression datasets, 12 pathways were found in GeneGO database that shared by four stages. Then, microRNA expression profiles and ChIP-seq data were integrated for the further pathway enrichment analysis. As a result, we suggest 5 of these pathways could be served as putative pathways in glioma. Among them, the pathway of TGF-beta-dependent induction of EMT via SMAD is of particular importance.ConclusionsOur results demonstrate that the meta-analysis based on systems biology level provide a more useful approach to study the molecule mechanism of complex disease. The integration of different types of omics data, including gene expression microarrays, microRNA and ChIP-seq data, suggest some common pathways correlated with glioma. These findings will offer useful potential candidates for targeted therapeutic intervention of glioma.

[1]  R. Giegerich,et al.  Fast and effective prediction of microRNA/target duplexes. , 2004, RNA.

[2]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[3]  A. Mortazavi,et al.  Genome-Wide Mapping of in Vivo Protein-DNA Interactions , 2007, Science.

[4]  Y. Song,et al.  NF‐κB as a potential molecular target for cancer therapy , 2007 .

[5]  Baolin Wu,et al.  Cancer outlier differential gene expression detection. , 2007, Biostatistics.

[6]  Ning Ma,et al.  BLAST+: architecture and applications , 2009, BMC Bioinformatics.

[7]  Eytan Domany,et al.  Outcome signature genes in breast cancer: is there a unique set? , 2004, Breast Cancer Research.

[8]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Steven Eschrich,et al.  Libaffy: software for processing Affymetrix(R) GeneChip(R) data , 2007, Bioinform..

[10]  Jun Li,et al.  Biomarkers , Genomics , Proteomics , and Gene Regulation miR-182 as a Prognostic Marker for Glioma Progression and Patient Survival , 2010 .

[11]  Lei Han,et al.  High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma , 2012, Journal of Translational Medicine.

[12]  Wei Li,et al.  Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion , 2010, Journal of experimental & clinical cancer research : CR.

[13]  Lei Han,et al.  MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol , 2010, BMC Cancer.

[14]  Rosette Lidereau,et al.  BMC Cancer BioMed Central Research article NF-kappa B genes have a major role in Inflammatory Breast Cancer , 2008 .

[15]  Andrei Zinovyev,et al.  [Systems biology of cancer]. , 2009, Medecine sciences : M/S.

[16]  R. Shiekhattar,et al.  MicroRNA biogenesis and cancer. , 2005, Cancer research.

[17]  Jiajia Chen,et al.  Identifying novel glioma associated pathways based on integrated ‘omics’ data , 2012, 2012 IEEE 6th International Conference on Systems Biology (ISB).

[18]  Ruian Xu,et al.  Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy. , 2009, Current cancer drug targets.

[19]  P. Brown,et al.  Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Wei Yu,et al.  The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis , 2011, BMC Genomics.

[21]  P. Park.  ChIP–seq: advantages and challenges of a maturing technology , 2009, Nature Reviews Genetics.

[22]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[23]  D. Tesfaye,et al.  cDNA microarray analysis of gene expression in parthenotes and in vitro produced buffalo embryos. , 2012, Theriogenology.

[24]  Lei Han,et al.  MicroRNA‐21 Expression is regulated by β‐catenin/STAT3 Pathway and Promotes Glioma Cell Invasion by Direct Targeting RECK , 2012, CNS neuroscience & therapeutics.

[25]  Jun Wang,et al.  Identification of the role of Smad interacting protein 1 (SIP1) in glioma , 2010, Journal of Neuro-Oncology.

[26]  Indu Khatri,et al.  Comparative microarray data analysis for the expression of genes in the pathway of glioma , 2010, Bioinformation.

[27]  D. White,et al.  Rel/NF-kappaB/IkappaB proteins and cancer. , 1996, Oncogene.

[28]  T. Nikolskaya,et al.  Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms , 2006, Xenobiotica; the fate of foreign compounds in biological systems.

[29]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[30]  George C. Tseng,et al.  Meta-analysis for pathway enrichment analysis when combining multiple genomic studies , 2010, Bioinform..

[31]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[32]  V. P. Collins,et al.  Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.

[33]  Dmitrij Frishman,et al.  TargetSpy: a supervised machine learning approach for microRNA target prediction , 2010, BMC Bioinformatics.

[34]  Allen D. Delaney,et al.  Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing , 2007, Nature Methods.

[35]  Marc Ferrer,et al.  Median Absolute Deviation to Improve Hit Selection for Genome-Scale RNAi Screens , 2008, Journal of biomolecular screening.

[36]  Debashis Ghosh,et al.  COPA - cancer outlier profile analysis , 2006, Bioinform..

[37]  Igor Goryanin,et al.  Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab. , 2009, Cancer research.

[38]  Peter J Park,et al.  Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers , 2009, Molecular Cancer.

[39]  Raja Jothi,et al.  Genome-wide identification of in vivo protein–DNA binding sites from ChIP-Seq data , 2008, Nucleic acids research.

[40]  David García-Dorado,et al.  TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. , 2009, Cancer cell.

[41]  Andrew P. Stubbs,et al.  Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology. , 2009, Cancer research.

[42]  Paola Pisani,et al.  Genetic Pathways to Glioblastoma , 2004, Cancer Research.

[43]  Kevin R. Coombes,et al.  Identifying Differentially Expressed Genes in cDNA Microarray Experiments , 2001, J. Comput. Biol..

[44]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[45]  Heidi Dvinge,et al.  PeakAnalyzer: Genome-wide annotation of chromatin binding and modification loci , 2010, BMC Bioinformatics.

[46]  Ying Wang,et al.  Identifying novel prostate cancer associated pathways based on integrative microarray data analysis , 2011, Comput. Biol. Chem..

[47]  Y. Song,et al.  NF-kappaB as a potential molecular target for cancer therapy. , 2007, BioFactors.

[48]  M. Honavar,et al.  Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas , 2012, PloS one.

[49]  G. Daley,et al.  Deciphering the rules of ceRNA networks , 2013, Proceedings of the National Academy of Sciences.